Indazolylketones as new multitarget cannabinoid drugs.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2019.01.030
Abstract: Multitarget cannabinoids could be a promising therapeutic strategic to fight against Alzheimer's disease. In this sense, our group has developed a new family of indazolylketones with multitarget profile including cannabinoids, cholinesterase and BACE-1 activity. A… read more here.
Keywords: new multitarget; multitarget; chemistry; indazolylketones new ... See more keywords